The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
CORM‐A1: a new pharmacologically active carbon monoxide‐releasing molecule
Open accessAbstract
Carbon monoxide (CO) is emerging as an important and versatile mediator of physiological processes to the extent that treatment of animals with exogenous CO gas has beneficial effects in a range of vascular‐ and inflammatory‐related disease models. The recent discovery that certain transition metal carbonyls function as CO‐releasing molecules (CO‐RMs) in biological systems highlighted the potential of exploiting this and similar classes of compounds as a stratagem to deliver CO for therapeutic purposes. Here we describe the biochemical features and pharmacological actions of a newly identified water‐soluble CO releaser (CORM‐A1) that, unlike the first prototypic molecule recently described (CORM‐3), does not contain a transition metal and liberates CO at a much slower rate under physiological conditions. Using a myoglobin assay and an amperometric CO electrode, we demonstrated that the release of CO from CORM‐A1 is both pH‐ and temperature‐dependent with a half‐life of ∼21 min at 37°C and pH 7.4. In isolated aortic rings, CORM‐A1 promoted a gradual but profound concentration‐dependent vasorelaxation over time, which was highly amplified by YC‐1 (1 µM) and attenuated by ODQ, a stimulator and inhibitor of guanylate cyclase, respectively. Similarly, administration of CORM‐A1 (30 µmol/kg i.v.) in vivo produced a mild decrease in mean arterial pressure, which was markedly potentiated by pretreatment with YC‐1 (1.2 µmol/kg i.v.). Interestingly, an inactive form of CORM‐A1 that is incapable of releasing CO failed to promote both vasorelaxation and hypotension, thus directly implicating CO as the mediator of the observed pharmacological effects. Our results reveal that the bioactivities exerted by CORM‐A1 reflect its intrinsic biochemical behavior of a slow CO releaser, which may be advantageous in the treatment of chronic conditions that require CO to be delivered in a carefully controlled manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE HEME OXYGENASE SYSTEM:A Regulator of Second Messenger Gases
Maines, M. D. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.517 · Cited by 2,505
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
Heme oxygenase-1: unleashing the protective properties of heme
Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166
Carbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998
Self-citationCarbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis
Brouard, S., Otterbein, L. E., Anrather, J., Tobiasch, E., Bach, F. H., Choi, A. M. K., & Soares, M. P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1015 · Cited by 984
Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673
Self-citationOtterbein, L. E., Zuckerbraun, B. S., Haga, M., Liu, F., Song, R., Usheva, A., Stachulak, C., Bodyak, N., Smith, R. N., Csizmadia, E., et al. (2003) · Nature Medicine · doi:10.1038/nm817 · Cited by 526
Sato, K., Balla, J., Otterbein, L., Smith, R. N., Brouard, S., Lin, Y., Csizmadia, E., Sevigny, J., Robson, S. C., Vercellotti, G., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.4185 · Cited by 461
Fujita, T., Toda, K., Karimova, A., Yan, S.-F., Naka, Y., Yet, S.-F., & Pinsky, D. J. (2001) · Nature Medicine · doi:10.1038/87929 · Cited by 398
Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme.
Friebe, A., Schultz, G., & Koesling, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01078.x · Cited by 352
Carbon Monoxide Controls the Proliferation of Hypoxic Vascular Smooth Muscle Cells
Morita, T., Mitsialis, S. A., Koike, H., Liu, Y., & Kourembanas, S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32804 · Cited by 332
Carbon monoxide‐induced vasorelaxation and the underlying mechanisms
Wang, R., Wang, Z., & Wu, L. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701222 · Cited by 331
Waibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., Egli, A., Abram, U., Mach, J.-P., Plückthun, A., et al. (1999) · Nature Biotechnology · doi:10.1038/12890 · Cited by 303
Self-citationVasoactive properties of CORM‐3, a novel water‐soluble carbon monoxide‐releasing molecule
Foresti, R., Hammad, J., Clark, J. E., Johnson, T. R., Mann, B. E., Friebe, A., Green, C. J., & Motterlini, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705825 · Cited by 303
Self-citationMotterlini, R., Gonzales, A., Foresti, R., Clark, J. E., Green, C. J., & Winslow, R. M. (1998) · Circulation Research · doi:10.1161/01.res.83.5.568 · Cited by 278
Self-citationForesti, R., & Motterlini, R. (1999) · Free Radical Research · doi:10.1080/10715769900301031 · Cited by 274
Self-citationEndothelial Heme Oxygenase-1 Induction by Hypoxia
Motterlini, R., Foresti, R., Bassi, R., Calabrese, V., Clark, J. E., & Green, C. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13613 · Cited by 263
Self-citationMetal Carbonyls: A New Class of Pharmaceuticals?
Johnson, T. R., Mann, B. E., Clark, J. E., Foresti, R., Green, C. J., & Motterlini, R. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200301634 · Cited by 261
Self-citationBioactivity and Pharmacological Actions of Carbon Monoxide-Releasing Molecules
Motterlini, R., Mann, B., Johnson, T., Clark, J., Foresti, R., & Green, C. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033453785 · Cited by 256
Self-citationSammut, I. A., Foresti, R., Clark, J. E., Exon, D. J., Vesely, M. J. J., Sarathchandra, P., Green, C. J., & Motterlini, R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702212 · Cited by 237
Self-citationAdministration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo
Guo, Y., Stein, A. B., Wu, W.-J., Tan, W., Zhu, X., Li, Q.-H., Dawn, B., Motterlini, R., & Bolli, R. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00971.2003 · Cited by 221
Self-citationLee, T.-S., Tsai, H.-L., & Chau, L.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300498200 · Cited by 211
Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor
Wang, R. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-1-1 · Cited by 201
Biological Chemistry of Carbon Monoxide
Piantadosi, C. A. (2002) · Antioxidants & Redox Signaling · doi:10.1089/152308602753666316 · Cited by 201
Józkowicz, A., Huk, I., Nigisch, A., Weigel, G., Dietrich, W., Motterlini, R., & Dulak, J. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603764816514 · Cited by 196
Self-citationPeyton, K. J., Reyna, S. V., Chapman, G. B., Ensenat, D., Liu, X., Wang, H., Schafer, A. I., & Durante, W. (2002) · Blood · doi:10.1182/blood.v99.12.4443 · Cited by 174
Regulation of Heme Oxygenase-1 by Redox Signals Involving Nitric Oxide
Motterlini, R., Green, C. J., & Foresti, R. (2002) · Antioxidants and Redox Signaling · doi:10.1089/15230860260220111 · Cited by 153
Self-citationCarbon monoxide attenuates aeroallergen-induced inflammation in mice
Chapman, J. T., Otterbein, L. E., Elias, J. A., & Choi, A. M. K. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l209 · Cited by 144
Carbon Monoxide: To Boldly Go Where NO Has Gone Before
Ryter, S. W., Morse, D., & Choi, A. M. K. (2004) · Science s STKE · doi:10.1126/stke.2302004re6 · Cited by 122
Induction of Heme Oxygenase 1 by Nitrosative Stress
NAUGHTON, P. J., Foresti, R., Bains, S. K., Hoque, M., Green, C. J., & Motterlini, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203863200 · Cited by 117
Self-citationXi, Q., Tcheranova, D., Parfenova, H., Horowitz, B., Leffler, C. W., & Jaggar, J. H. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00782.2003 · Cited by 103
Choi, B.-M., Pae, H., Kim, Y., & Chung, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50114 · Cited by 94
Carbon Monoxide and Cardiovascular Functions
Wang, R. (2001) · CRC Press eBooks · doi:10.1201/9781420041019 · Cited by 86
Fiumana, E., Parfenova, H., Jaggar, J. H., & Leffler, C. W. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00881.2002 · Cited by 82
Acute renal hemodynamic effects of dimanganese decacarbonyl and cobalt protoporphyrin
Arregui, B., López, B., Salom, M. G., Valero, F., Navarro, C. S., & Fenoy, F. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00409.x · Cited by 82
Wakabayashi, Y., Takamiya, R., Mizuki, A., Kyokane, T., Goda, N., Yamaguchi, T., Takeoka, S., Tsuchida, E., Suematsu, M., & Ishimura, Y. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.5.g1088 · Cited by 74
Nitric oxide priming protects nitric oxide-mediated apoptosis via HEME OXYGENASE-1 induction
Choi, B., Pae, H., & Chung, H. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00064-9 · Cited by 72
Foresti, R., Green, C. J., & Motterlini, R. (2004) · Biochemical Society Symposia · doi:10.1042/bss0710177 · Cited by 65
Self-citationTongers, J., Fiedler, B., König, D., Kempf, T., Klein, G., Heineke, J., Kraft, T., Gambaryan, S., Lohmann, S. M., Drexler, H., et al. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.015 · Cited by 60
Bak, I., Szendrei, L., Turóczi, T., Papp, G., Joó, F., Das, D. K., de Leiris, J., Dér, P., Juhász, B., Varga, E., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0032fje · Cited by 57
Stanford, S. J., Walters, M. J., Hislop, A. A., Haworth, S. G., Evans, T. W., Mann, B. E., Motterlini, R., & Mitchell, J. A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02001-6 · Cited by 42
Self-citation
Cited by
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
Ryter, S. W., Alam, J., & Choi, A. M. K. (2006) · Physiological Reviews · doi:10.1152/physrev.00011.2005 · Cited by 2,307
The therapeutic potential of carbon monoxide
Motterlini, R., & Otterbein, L. E. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3228 · Cited by 1,638
Self-citationPharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115
“In recent years, CORMs have been developed to facilitate CO delivery and prolong its bioactions, especially in vascular protection (Motterlini et al., 2002, 2005).”
Developing drug molecules for therapy with carbon monoxide
Romão, C. C., Blättler, W. A., Seixas, J. D., & Bernardes, G. J. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15317c · Cited by 524
Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706241 · Cited by 391
Metadata
- Authors
- Motterlini, R., Sawle, P., Bains, S., Hammad, J., Alberto, R., Foresti, R., & Green, C. J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2004-11-19
- Volume
- 19
- Issue
- 2
- Pages
- 1-24
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2000312541
- Cited by
- 385
- References
- 41
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.